ALS is associated with a specific dysbiotic gut ecosystem characterized by the loss of protective commensals, unique viral signatures, and functional metabolic reprogramming that exacerbates host oxidative stress and energy deficits.
Global gut microbiome diversity indices showed no significant differences between ALS patients and controls, despite distinct compositional shifts at the taxonomic level.
The ALS gut microbiome showed significant depletion of beneficial anti-inflammatory genera Akkermansia and Faecalibacterium.
The ALS gut microbiome showed expansion of opportunistic pathogens including Escherichia and oral-associated taxa such as Streptococcus.
Specific gut virome alterations were identified in ALS patients, with viral genera Puppervirus and Donellivirus enriched compared to controls.
The ALS microbiome exhibited marked upregulation of microbial pathways involved in L-ascorbate (vitamin C) degradation and fatty acid biosynthesis.
Metabolomic analysis identified 271 differentially expressed metabolites in ALS patients compared to controls.
Integrative multi-omics analysis highlighted profound dysregulation in porphyrin metabolism, oxidative phosphorylation, and energy homeostasis in ALS patients.
Microbial antioxidant depletion was highlighted as a potential therapeutic target based on the integrated findings.
This research suggests that people with ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease) have a distinctly altered gut ecosystem compared to healthy individuals. Using advanced DNA sequencing and chemical analysis techniques applied simultaneously to the same samples (a multi-omics approach), the researchers studied the bacteria, viruses, and small molecules present in the guts of Chinese ALS patients. They found that while the overall number and variety of gut microbes appeared similar between ALS patients and healthy controls, the specific types of microbes present were quite different—ALS patients had lost beneficial bacteria that normally protect the gut lining and reduce inflammation (particularly Akkermansia and Faecalibacterium), and had gained more potentially harmful bacteria typically associated with infections or the mouth. Beyond identifying which microbes were present, the study found that the ALS gut microbiome was functionally different in important ways. The bacteria in ALS patients' guts were more active at breaking down vitamin C, a key antioxidant, and at producing certain fats. The chemical analysis confirmed these findings, showing that ALS patients had higher levels of inflammatory molecules and lower levels of protective antioxidants in their systems, as well as disruptions in how cells produce energy. A unique pattern of gut viruses was also identified in ALS patients, adding another layer to the complex picture of gut changes in this disease. This research suggests that the gut microbiome in ALS may not just be passively altered but could be actively contributing to disease progression by depleting antioxidants and disrupting energy metabolism—two processes already known to be impaired in ALS. These findings matter because they point to potentially new treatment avenues, such as targeting specific bacterial activities that degrade antioxidants, or supplementing metabolites that are being depleted. While this was a study in Chinese patients and further research is needed to confirm these findings in other populations and establish causality, it provides new insights into the gut-brain connection in ALS.
Ma X, Jiang Z, Yang T, Zhang H, Lu W, Liu K, et al.. (2026). Integrated multi-omics analysis reveals gut dysbiosis and altered energy metabolism in Chinese ALS patients.. Microbiology spectrum. https://doi.org/10.1128/spectrum.00609-26